GAO Tian-xiao, LI Zhi-ming, WEI Xiao-juan. The Influence of Rituximab, High-Dose Chemotherapy with Primary Central Nervous System Lymphoma[J]. Journal of Evidence-Based Medicine, 2018, 18(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2018.02.008
|
Citation:
|
GAO Tian-xiao, LI Zhi-ming, WEI Xiao-juan. The Influence of Rituximab, High-Dose Chemotherapy with Primary Central Nervous System Lymphoma[J]. Journal of Evidence-Based Medicine, 2018, 18(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2018.02.008
|
GAO Tian-xiao, LI Zhi-ming, WEI Xiao-juan. The Influence of Rituximab, High-Dose Chemotherapy with Primary Central Nervous System Lymphoma[J]. Journal of Evidence-Based Medicine, 2018, 18(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2018.02.008
|
Citation:
|
GAO Tian-xiao, LI Zhi-ming, WEI Xiao-juan. The Influence of Rituximab, High-Dose Chemotherapy with Primary Central Nervous System Lymphoma[J]. Journal of Evidence-Based Medicine, 2018, 18(2): 85-87. DOI: 10.12019/j.issn.1671-5144.2018.02.008
|
DownLoad: